Table 3 Rituximab response distribution
Patient # | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | Median |
|---|---|---|---|---|---|---|---|---|---|
Months to 1st RTX Infusion | 26 | 1.5 | 27 | 3 | 7 | 25 | 3 | 96 | 16 |
Number of rounds of RTX (2 doses/round) | 3 | 2 | 1 | 1 | 1 | 1 | 6 | 3 | 1.5 |
Hospitalizations for HSP prior to RTX | 2 | 1 | 1 | 2 | 1 | 3 | 2 | 0 | 1.5 |
Hospitalizations for HSP post RTX | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Months in remission as of July 2016 | 70 | 73 | 49 | 60 | 66 | 91 | 1 | N/A | 63 |